A Study Of Patient Self-Collection

Overview

About this study

The purpose of this study is to evaluate the performance of the EZDraw capillary blood collection device when used for supervised self‑collection in adults aged ≥50 years.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults >18

  • Able to understand instructions in written and spoken English

  • Willing and able to sign an Informed Consent Form

  • Respondents must be able to verbalize well.


Exclusion Criteria:

  • A history of problems with venous blood drawing (fainting, clotting abnormalities, prolonged bruising, etc.) 

  • Allergies to stainless steel or the device adhesives (acrylic adhesive) 

  • Skin irritation, injured skin, or skin disease at the targeted site (outer side of upper arms)  

  • Excessive scarring at the targeted site (outer side of the upper arms) 

  • Subcutaneous implants in the targeted site (outer side of the upper arms) 

  • Hemophilia and those receiving anticoagulant therapy 

  • Decisional impaired: Healthy volunteers unable to provide informed consent due to cognitive impairment, developmental disability, or other mental health conditions affecting decision-making capacity. 

  • Hospitalized patients: cannot be able to participate in the study due to their medical condition or limited mobility.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 05/18/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Meeusen, Ph.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions